Drug intelligence / Profile preview

18F-DTPA

Development stage
Preclinical
Lead developer
Technical University of Munich
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

18F-DTPA is a fluorine-18-labeled radioligand developed by the Technical University of Munich (TUM) as part of a novel bioorthogonal positron emission tomography (PET) reporter gene system (DTPA-R). The system consists of a membrane-anchored reporter protein, DTPA-R (comprising the engineered lipocalin Anticalin CL31d), which binds the 18F-DTPA lanthanide complex with picomolar affinity. 18F-DTPA is designed for non-invasive, quantitative, and high-contrast whole-body PET imaging to track the biodistribution, proliferation, and migration of advanced therapies, such as chimeric antigen receptor (CAR) T-cells, adeno-associated virus (AAV) gene therapies, and human induced pluripotent stem cell (hiPSC)-derived cardiac progenitors.

Other names
[18F]F-DTPA[18F]F-DTPA*Tb[18F]F-DTPA•Tb[18F]F-DTPA•TbIII[18F]F-Nic-Glu2-PEG4-CHX-A''-DTPA•metal[18F]F-Nic-Glu2-PEG4-CHX-A''-DTPA•Tb18F-DTPA-Tb18F-labeled DTPA

Beyond the preview

Go deeper on 18F-DTPA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18F-DTPA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call